| Authors: |
Lustig M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Kowol M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Hartmann AM; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., van der Peet IC; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen MJH; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Iben K; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Winterberg D; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Krohn S; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Baumann N; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Rösner T; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Bendig S; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Hahn C; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Wurm AA; Pediatric Hematology/Oncology, TU Dresden and University Medical Center Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden Partner Site, Dresden, Germany., Gehlert CL; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Denker M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Suwanchaikasem P; Baiya Phytopharm Co, Ltd, Bangkok, Thailand., Macarrón Palacios A; GenCC GmbH & Co KG, Heidelberg, Germany., Schwartz S; Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, a partnership between German Cancer Research Center and Charité Universitätsmedizin Berlin, Berlin, Germany., Brüggemann M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Burger R; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Schmitt K; Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Georg-August-University of Göttingen, Göttingen, Germany.; Service Unit LCMS Protein Analytics, Göttingen Center for Molecular Biosciences (GZMB), Georg-August-University of Göttingen, Göttingen, Germany., Klausz K; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Valerius O; Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Georg-August-University of Göttingen, Göttingen, Germany.; Service Unit LCMS Protein Analytics, Göttingen Center for Molecular Biosciences (GZMB), Georg-August-University of Göttingen, Göttingen, Germany., Stölzel F; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Bastian L; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Baldus CD; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Peipp M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Leusen JHW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Schewe DM; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.; Pediatric Hematology/Oncology, TU Dresden and University Medical Center Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden Partner Site, Dresden, Germany., Valerius T; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany. |
